focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,754.50
Bid: 1,754.00
Ask: 1,755.00
Change: -20.50 (-1.15%)
Spread: 1.00 (0.057%)
Open: 1,770.00
High: 1,770.00
Low: 1,750.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Stocks at one-month high on Vodafone capital return

Fri, 21st Feb 2014 11:45

- Vodafone and RBS provide a lift- Vodafone capital return lifts sentiment- IHG, Glencore Xstrata hit by downgrades- FTSE 100 at highest level in monthtechMARK 2,884.38 +0.29%FTSE 100 6,827.26 +0.21%FTSE 250 16,401.56 +0.20%UK stocks rose to levels not seen in a month on Friday as a windfall for investors at Vodafone and rumoured restructuring plans at RBS gave sentiment a lift.Markets were particularly buoyant this morning as investors speculated about which stocks could benefit from Vodafone shareholders redistributing their cash following the group's $130bn deal to sell its 45% stake in Verizon Wireless.According to analysts at Bank of America Merrill Lynch, the deal, which completes today, will be the largest capital return in corporate history and will have a drastic impact on UK trading volumes over the next few weeks.The FTSE 100 had pared gains by midday but was still trading 0.2% higher at 6,827; it has not closed above this level since January 21st. "London's main index holds above the 6,800 level for now, putting it in a position to challenge the January high of 6,867; providing the positive mood is sustained into the final week of February," said Chris Beauchamp, Market Analyst at IG. He said that the current rally "may have a little further to run".Investors largely shrugged off data this morning showing a worse-than-expected 1.5% fall in UK retail sales volumes in January. Vodafone, RBS and Glaxo provide a liftTelecoms titan Vodafone was making decent gains this morning with shareholders today set to receive a windfall from the company's sale of its holding in its US joint venture with Verizon.RBS was higher amid reports that the bank will announce plans to slash as many as 30,000 jobs, reducing its staff count to the lowest levels in more than 10 years. The speculation comes ahead of the group's 2013 results due out next week, alongside which it is expected to unveil a massive restructuring programme of its divisions.Pharmaceuticals giant GlaxoSmithKline edged higher after European regulators recommended marketing authorisation for umeclidinium, its once-daily treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease.Millennium & Copthorne, the hotel firm, jumped after reporting record revenues and profits for 2013 as fourth-quarter results were boosted by the one-off sale of the bulk of the Glyndebourne development in Singapore.Sector peer InterContinental Hotels Group, however, was trading in the red after Credit Suisse lowered its recommendation from 'neutral' to 'underperform', pointing out that the shares are trading within just 4% of their all-time high at a price-to-earnings ratio of 23.Glencore Xstrata was also lower after JPMorgan Cazenove downgraded its rating on the stock from 'overweight' to 'neutral', saying that its peers have overtaken it in terms of capital returns potential.BAE Systems, which disappointed the market with its 2014 guidance yesterday, bounced slightly this morning after Societe Generale raised the stock from 'hold' to 'buy'.FTSE 100 - RisersRoyal Bank of Scotland Group (RBS) 364.10p +2.36%BAE Systems (BA.) 409.00p +2.15%ARM Holdings (ARM) 965.00p +1.90%Vodafone Group (VOD) 233.65p +1.76%Persimmon (PSN) 1,460.00p +1.60%Weir Group (WEIR) 2,355.00p +1.16%Travis Perkins (TPK) 1,984.00p +0.92%Randgold Resources Ltd. (RRS) 4,825.00p +0.81%Severn Trent (SVT) 1,812.00p +0.78%Wolseley (WOS) 3,342.00p +0.75%FTSE 100 - FallersInterContinental Hotels Group (IHG) 1,922.00p -2.68%IMI (IMI) 1,530.00p -2.24%Smiths Group (SMIN) 1,361.00p -2.09%Bunzl (BNZL) 1,469.00p -1.34%easyJet (EZJ) 1,727.00p -1.20%Prudential (PRU) 1,340.00p -1.11%International Consolidated Airlines Group SA (CDI) (IAG) 445.70p -1.07%Meggitt (MGGT) 509.00p -1.07%Glencore Xstrata (GLEN) 336.90p -1.04%ITV (ITV) 205.70p -1.01%FTSE 250 - RisersIP Group (IPO) 231.00p +7.89%Millennium & Copthorne Hotels (MLC) 598.50p +4.72%Essentra (ESNT) 882.00p +4.38%Centamin (DI) (CEY) 52.35p +3.77%Imagination Technologies Group (IMG) 187.90p +2.96%Ocado Group (OCDO) 598.00p +2.48%Big Yellow Group (BYG) 562.00p +2.46%RPC Group (RPC) 630.00p +2.36%Hunting (HTG) 838.00p +2.20%Polymetal International (POLY) 655.00p +2.18%FTSE 250 - FallersVesuvius (VSVS) 458.20p -2.86%Domino's Pizza Group (DOM) 535.00p -2.37%Evraz (EVR) 81.80p -1.56%Rank Group (RNK) 145.00p -1.56%3i Group (III) 400.50p -1.50%PZ Cussons (PZC) 358.80p -1.46%Hellermanntyton Group (HTY) 305.30p -1.45%Synthomer (SYNT) 270.20p -1.39%Cranswick (CWK) 1,288.00p -1.38%Bank of Georgia Holdings (BGEO) 2,375.00p -1.29%BC
More News
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.